CRON: 4 Canadian Cannabis Stocks to Avoid in March stocknews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stocknews.com Daily Mail and Mail on Sunday newspapers.
VANCOUVER, British Columbia, Jan. 27, 2021 (GLOBE NEWSWIRE) â
Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV)Â (âJuva Life,â âJuvaâ or the âCompanyâ
), a California based life sciences company focused on the research and development, and commercialization of Cannabis products is pleased to offer an update regarding intellectual property protection matters and concurrent capital markets activities.
Juva Life is a life science company focused on the identification and characterization of evidenced based safe cannabis products. The Company has developed a unique platform that enables the identification of products targeting inflammatory conditions. Juva will protect these inventions through holding as trade secret certain discovery technologies and patenting novel compositions of matter and uses. Directing these activities within the Company is Sanjeev Gangwar, Ph.D., Vice President of Chemistry. Dr. Gangwar brings significant experien
#3 This Is A Big Data Coup
Cannabis data is the difference between a successful market and a
very successful market.
It’s the only thing connecting medical cannabis to medical science …
It’s the missing element that could cut millions of dollars off the costs of getting new cannabis based pharmaceutical drugs approved …
That also means it’s one thing that will attract the lucrative attention of Big Pharma.
It’s also one thing Juva has brought to the table.
And when the company went public in November, it heralded a business plan of creating a potential lucrative nexus between medical cannabis and big pharma.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Juva Life Initiates Clinical Registry as First Step in Building Evidence-Based Cannabis .
Juva Life Inc.January 21, 2021 GMT
VANCOUVER, British Columbia, Jan. 21, 2021 (GLOBE NEWSWIRE) Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a California-based life science company today announces the launch of a clinical registry to evaluate rationally designed cannabis formulations for clinical effect and mode of action. This is the first step towards building an integrated technology platform addressing serious and unmet medical needs.
There is a substantial body of pre-clinical, clinical, and anecdotal data consistent with a cannabis effect, but despite significant investment and opportunity, there is an absence of understanding of “how cannabis works” to pair the right formulation with the right indication. Juva has de
FREE
Only logged in users are allowed to post comments. Register/ Log in
The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2021 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted.
Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any